Pierce et al., Hematol J 2001
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
This enhanced BCR/ABL mediated growth inhibition occurred over a range of growth factor concentrations and was independent of changes in p21 ( Cip1 ) and p27 ( Kip ) levels
Keeshan et al., Br J Haematol 2003
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Bcr-Abl upregulates cytosolic p21WAF-1/CIP-1 by a phosphoinositide-3-kinase (PI3K) independent pathway